62.57
price up icon2.64%   1.61
after-market After Hours: 62.57
loading
Bio Techne Corp stock is traded at $62.57, with a volume of 2.11M. It is up +2.64% in the last 24 hours and up +12.48% over the past month. Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
See More
Previous Close:
$60.96
Open:
$60.81
24h Volume:
2.11M
Relative Volume:
0.92
Market Cap:
$9.74B
Revenue:
$1.17B
Net Income/Loss:
$150.71M
P/E Ratio:
66.56
EPS:
0.94
Net Cash Flow:
$245.03M
1W Performance:
-5.06%
1M Performance:
+12.48%
6M Performance:
+24.27%
1Y Performance:
-15.16%
1-Day Range:
Value
$60.48
$62.96
1-Week Range:
Value
$60.48
$65.86
52-Week Range:
Value
$46.01
$80.80

Bio Techne Corp Stock (TECH) Company Profile

Name
Name
Bio Techne Corp
Name
Phone
(612) 379-8854
Name
Address
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
Employee
3,100
Name
Twitter
@biotechne
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
TECH's Discussions on Twitter

Compare TECH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TECH
Bio Techne Corp
62.57 9.49B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 398.11M -1.03B -868.57M -5.7032

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-03-25 Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-21-25 Upgrade Citigroup Neutral → Buy
Jul-22-25 Resumed Stephens Overweight
Jul-09-25 Initiated TD Cowen Buy
May-30-25 Initiated Wells Fargo Overweight
Apr-09-25 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-18-25 Initiated Evercore ISI Outperform
Feb-19-25 Downgrade Robert W. Baird Outperform → Neutral
May-22-24 Downgrade Citigroup Buy → Neutral
Feb-08-24 Initiated Scotiabank Sector Outperform
Feb-02-24 Downgrade Stifel Buy → Hold
Dec-07-23 Initiated UBS Buy
Aug-28-23 Initiated William Blair Outperform
Jan-10-23 Upgrade Wells Fargo Underweight → Equal Weight
Dec-14-22 Initiated Deutsche Bank Buy
Dec-12-22 Upgrade Citigroup Neutral → Buy
Dec-07-22 Initiated RBC Capital Mkts Sector Perform
Aug-25-22 Initiated Credit Suisse Outperform
Apr-25-22 Downgrade Wells Fargo Equal Weight → Underweight
Sep-15-21 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-08-21 Upgrade Stephens Equal-Weight → Overweight
Feb-23-21 Upgrade Stifel Hold → Buy
Jan-25-21 Reiterated The Benchmark Company Buy
Nov-10-20 Initiated KeyBanc Capital Markets Sector Weight
Sep-30-20 Initiated Atlantic Equities Overweight
Jul-15-20 Downgrade Stephens Overweight → Equal-Weight
May-27-20 Downgrade Stifel Buy → Hold
May-14-20 Initiated The Benchmark Company Buy
Jan-08-20 Resumed Stephens Overweight
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Neutral
Nov-15-19 Initiated Stifel Buy
Jul-02-19 Upgrade Janney Neutral → Buy
Jan-14-19 Upgrade Stephens Equal-Weight → Overweight
Oct-31-18 Downgrade Craig Hallum Buy → Hold
Oct-17-18 Initiated Goldman Neutral
Jun-15-18 Initiated Argus Buy
Jul-13-17 Initiated Wells Fargo Market Perform
Feb-09-17 Initiated Citigroup Buy
Jan-18-17 Initiated Deutsche Bank Buy
Nov-10-16 Resumed Leerink Partners Outperform
Jan-21-15 Reiterated Robert W. Baird Outperform
Sep-20-13 Upgrade Robert W. Baird Neutral → Outperform
View All

Bio Techne Corp Stock (TECH) Latest News

pulisher
04:46 AM

Is Bio Techne Corporation stock a contrarian buyJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com

04:46 AM
pulisher
03:44 AM

Why Bio Techne Corporation (TE1) stock could outperform next yearTrade Analysis Summary & Safe Swing Trade Setups - newser.com

03:44 AM
pulisher
02:46 AM

Statistical indicators supporting Bio Techne Corporation’s strength2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com

02:46 AM
pulisher
02:10 AM

Published on: 2025-10-31 01:10:28 - newser.com

02:10 AM
pulisher
01:52 AM

How to forecast Bio Techne Corporation trends using time seriesQuarterly Profit Report & Daily Market Momentum Tracking - newser.com

01:52 AM
pulisher
01:26 AM

Will Bio Techne Corporation (TE1) stock hit Wall Street targetsCEO Change & Verified Technical Signals - newser.com

01:26 AM
pulisher
Oct 30, 2025

Bio-Techne Corp. Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Is Bio Techne Corporation (TE1) stock overpriced at current multiplesJuly 2025 Review & Weekly Breakout Watchlists - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Ownership Capital B.V. Cuts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Why Bio Techne Corporation stock could benefit from AI revolution2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Bio-Techne Corp $TECH Shares Purchased by Nisa Investment Advisors LLC - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Heatmap analysis for Bio Techne Corporation and competitorsCPI Data & Proven Capital Preservation Methods - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is Bio Techne Corporation (TE1) stock positioned for secular growthTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Can trapped investors hope for a rebound in Bio Techne Corporation2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How analysts revise price targets for Bio Techne Corporation (TE1) stockJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Bio-Techne (TECH) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

How Investors Are Reacting To Bio-Techne (TECH) Unveiling Its ProximityScope Spatial Biology Assay - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Bio-techne launches new assay for protein interaction visualization - Investing.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Bio Techne Corporation benefit from macro trendsMarket Volume Summary & Low Drawdown Momentum Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Bio-Techne (NASDAQ: TECH) launches ProximityScope on BOND RX for protein interactions - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

How to use Fibonacci retracement on Bio Techne CorporationWeekly Market Report & Growth Focused Stock Pick Reports - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Bio Techne Corporation (TE1) stock a top hedge fund pick2025 Short Interest & Community Consensus Picks - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Will Bio Techne Corporation price bounce be sustainable2025 Sector Review & Stock Portfolio Risk Control - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

4,462 Shares in Bio-Techne Corp $TECH Bought by Sage Mountain Advisors LLC - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

First Citizens Bank & Trust Co. Sells 4,691 Shares of Bio-Techne Corp $TECH - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Can Bio Techne Corporation stock deliver consistent earnings growthJuly 2025 Volume & AI Optimized Trade Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Smart tools for monitoring Bio Techne Corporation’s price action2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

What to expect from Bio Techne Corporation in the next 30 daysChart Signals & Community Trade Idea Sharing Platform - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

What to do if you’re stuck in Bio Techne CorporationGap Down & Fast Entry and Exit Trade Plans - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Bio-Techne Corp $TECH Shares Bought by Sumitomo Mitsui Trust Group Inc. - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Comparing Bio Techne Corporation in custom built stock radarsJuly 2025 Opening Moves & Fast Gaining Stock Reports - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

Will Bio Techne Corporation stock benefit from sector rotationMarket Sentiment Review & Comprehensive Market Scan Reports - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

How institutional ownership impacts Bio Techne Corporation stock2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com

Oct 25, 2025

Bio Techne Corp Stock (TECH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Bio Techne Corp Stock (TECH) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Nusse Roeland
Director
Aug 25 '25
Sale
56.36
17,040
960,388
44,559
BAUMGARTNER ROBERT V
Director
Aug 25 '25
Option Exercise
21.84
17,040
372,154
61,903
BAUMGARTNER ROBERT V
Director
Aug 25 '25
Sale
56.21
17,040
957,818
44,863
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Cap:     |  Volume (24h):